METHOD FOR INTERRUPTING ALCOHOLIC ABSTINENT SYNDROME, DELIRIUM TREMENS, ACUTE ALCOHOLIC HALLUCINOSIS

FIELD: medicine, narcology. SUBSTANCE: one should introduce naloxon parenterally at the dosage of 0.4-0.8 mg/intake in 0.25-4.0 h till the onset of medicinal dream at further introduction of the above-mentioned preparation after awakening till regress of clinical symptomatics. The present innovation...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	GORBACH V.V, MAKARCHUK V.A, VLASOV A.A, MEL'NIK V.I, IZAROVSKIJ B.V, VINOGRADOV D.B
Format:	Patent
Sprache:	eng ; rus
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	FIELD: medicine, narcology. SUBSTANCE: one should introduce naloxon parenterally at the dosage of 0.4-0.8 mg/intake in 0.25-4.0 h till the onset of medicinal dream at further introduction of the above-mentioned preparation after awakening till regress of clinical symptomatics. The present innovation enables to simultaneously reduce several clinical symptoms in more shortened time intervals. EFFECT: higher efficiency. 1 ex, 1 tbl